Zacco partners with BioInnovation Institute
9 August 2019
A new partnership between Zacco and BioInnovation Institute (BII) in Denmark will help start-ups manage their IP.
BioInnovation Institute (BII) is an international hub for research-based innovation and entrepreneurship, which offers programs for start-ups, mainly focused on medtech, pharma and biotech.
Zacco will offer basic IP consultancy for all start-ups free of charge in two programs: Business Acceleration Academy and Creation House. Every week during the programs, Zacco will be present at BioInnovation Institute and available for consultancy for the start-ups.
Patent Attorney, Partner and Team Manager at Zacco, Niels Abrahamsen will advise the BII start-ups together with his team of skilled attorneys from Zacco. In an interview with BII, Niels explains a bit about how he and his team work with start-ups:
– We go through the start-ups’ business plans to understand what they work with and based on that we develop a check-list of things that are important to be in control of to attract investors. It is crucial for start-ups to be on top of their IP situation as well as to understand competition and which challenges they could be facing in the near or distant future regarding IP.
You can read the entire interview with Niels Abrahamsen here.Back to all news
- Zacco welcomes two Digital Brand experts to the team: Alexander Karlsson and Renaud Permezel26 January 2023
- Copyright chaos creates Christmas classic22 December 2022
- Season’s Greetings 202216 December 2022
- Lone Prehn wins Client Choice Awards 2022 for Trademarks in Denmark15 November 2022
- Zacco supports and partners with Star for Life Ukraine28 October 2022
- Meet Amin and Navid, our newly authorised EPA’s at the Gothenburg office6 October 2022
- Five colleagues announced as MIP Rising Stars 2022!4 October 2022
- Zacco takes home Trademark Prosecution Firm of the Year for Sweden16 September 2022
- Vacation is a time to relax, but don’t let your digital guard down13 July 2022
- UK Government publishes its response to a public consultation on AI and IP5 July 2022